yuvaneshwari
☆    

India,
2019-04-18 11:12
(519 d 05:25 ago)

Posting: # 20188
Views: 1,922
 

 Is FDA dissolution database more preferable to product specific FDA BE guidance? [Dissolution / BCS / IVIVC]

For a Oral solid dosage form [tablet and suspension], FDA dissolution database is recommending dissolution to be done at 25 degrees whereas, product specific FDA guidance for the same product is mentioning 37 degrees.

Which temperature should i need to adapt and follow for generic development ?


Edit: Please follow the Forum’s Policy[Helmut]
Vineeth KE
☆    

India,
2019-04-25 13:15
(512 d 03:22 ago)

@ yuvaneshwari
Posting: # 20229
Views: 1,476
 

 Is FDA dissolution database more preferable to product specific FDA BE guidance?

» For a Oral solid dosage form [tablet and suspension], FDA dissolution database is recommending dissolution to be done at 25 degrees whereas, product specific FDA guidance for the same product is mentioning 37 degrees.
»
» Which temperature should i need to adapt and follow for generic development ?

For development purpose, it is advisable to follow 37 degrees, as it mimics in-vivo condition (For oral solid dosage form).

If the drug release is affected by temperature (due to API solubility/Surfactant Solubility in dissolution media/API degradation/gelling of excipients or any other reasons), it is better to consider the worst case scenario (25 or 37degrees).

For submission purpose, we need to evaluate in both the conditions as mentioned in FDA-Dissolution database & FDA-Product specific guidance.
Activity
 Admin contact
21,068 posts in 4,392 threads, 1,463 registered users;
online 11 (0 registered, 11 guests [including 7 identified bots]).
Forum time: Friday 16:37 CEST (Europe/Vienna)

The great enemy of the truth is very often not the lie–
deliberate, contrived and dishonest—but the myth—
persistent, persuasive and unrealistic.    John F. Kennedy

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5